Evidence method
Level · gp.fundamentals.debt_to_revenue
7433.09% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
LXRX · Jun 30, 2026
LEXICON PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001062822-26-000117General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1328.32% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-97.60% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
172.83% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
94.36% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-3835.26% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2520.66% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
476.88% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20250/9 normalizedLevel 3Mar 31, 20266/8 normalizedLevel 3Jun 30, 20266/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 235.45%
- Current
- 7433.09%
- Delta
- 7197.65%
- Previous
- -69.80%
- Current
- -1328.32%
- Delta
- -1258.52%
- Previous
- 1572.11%
- Current
- -97.60%
- Delta
- -1669.71%
- Previous
- 1.31%
- Current
- 172.83%
- Delta
- 171.52%
- Previous
- 99.49%
- Current
- 94.36%
- Delta
- -5.12%
- Previous
- -4.72%
- Current
- -3835.26%
- Delta
- -3830.54%
- Previous
- 60.45%
- Current
- 2520.66%
- Delta
- 2460.22%
- Previous
- 14.59%
- Current
- 476.88%
- Delta
- 462.29%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · LEXICON PHARMACEUTICALS, INC. →Transitioned To · LXRX CASH_GENERATION_DECREASED →Transitioned To · LXRX GROWTH_DECREASED →Transitioned To · LXRX INVENTORY_PRESSURE_INCREASED →Transitioned To · LXRX MARGIN_DECREASED →Transitioned To · LXRX PROFITABILITY_DECREASED →Transitioned To · LXRX R_AND_D_INTENSITY_INCREASED →Transitioned To · LXRX SBC_INTENSITY_INCREASED →Transitioned To · LXRX Fundamental State →Transitioned To · LXRX BALANCE_SHEET_LEVERAGE_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.